 access during TEVAR ....
Femoral access ....................................................................
Iliac or aortic access ........................................................
Endoconduit ..........................................................................
Carotid-axillary access ...................................................
Recommendations for treatment of
symptomatic and ruptured TAAs .............................
SURVEILLANCE AFTER TEVAR .........................................
Implementation remarks about surveillance ..
SPECIAL TAA CONSIDERATIONS ....................................
CONCLUSIONS ...........................................................................

69S
70S
70S
